Wiregraph

Market coverage built from listed-company disclosures. Email [email protected] for any enquiries.

Copyright © 2025-2026 Wiregraph.com | Market data and charting by TradingView.com

INVESTOR B

INVEb.STSE0015811963NASDAQ StockholmSESEK
Stock price
INVESTOR B
Loading chart...

Coverage

Latest articles

Investor AB Q3 net asset value rises 7% as Nova Biomedical deal closes
16 Oct 2025, 06:16INVEb.STNASDAQ Stockholm

Filings

Recent filings

FilingDate
Investor supports EQT’s acquisition of Baring Private Equity Asia16 Mar 2022
Year-End Report 202121 Jan 2022
Investor AB’s Year-End Report 2021 webcast conference call14 Jan 2022
Investor AB comments on the withdrawal of Agnafit Bidco’s bid for Sobi3 Dec 2021
Interim Management Statement January-September 202118 Oct 2021
Investor AB’s Interim Management Statement January-September 2021 and Conference Call8 Oct 2021
Investor AB sharpens climate targets and joins “Race to Zero”27 Sept 2021
Investor AB’s Nomination Committee for the 2022 Annual General Meeting
Search

Swedish investment firm Investor AB on Thursday reported a 7% rise in its adjusted net asset value to 1,028.0 billion Swedish kronor for the third quarter, outperforming the local stock market.

Investor AB shares lag market despite rising asset value
17 Jul 2025, 06:17INVEb.STNASDAQ Stockholm

Investor AB on Thursday reported its net asset value grew in the second quarter, but its shares lagged the wider market.

Investor AB completes $2.2 billion U.S. med-tech acquisition
10 Jul 2025, 16:01INVEb.STNASDAQ Stockholm

Swedish investment firm Investor AB said on Thursday its subsidiary, Advanced Instruments, has completed the acquisition of U.S. medical technology company Nova Biomedical after receiving regulatory approval.

13 Sept 2021
Patricia Industries funds strategic add-on acquisition by Sarnova7 Sept 2021
Investor supports Agnafit Bidco’s bid for Sobi2 Sept 2021
Patricia Industries to fund strategic add-on acquisition by Advanced Instruments5 Aug 2021
Patricia Industries’ holding Atlas Antibodies acquires evitria, leader in recombinant antibody expression28 Jul 2021
  • Previous
  • 1
  • More pages
  • 7
  • 8
  • 9
  • More pages
  • 36
  • Next
Company
INVESTOR B
INVEb.STNASDAQ Stockholm
Website: Unavailable
Coverage
3
Filings
426